Health care M&A volume remained stable in third quarter of 2024

Activity in sectors such as physician medical groups and other services drove much of the volume in the third quarter, with 112 and 140 deals, respectively.

Nearly 500 health care mergers and acquisitions were announced in the recently completed third quarter, nearly the same as the second quarter but 4% less than the third quarter of 2023.

“There’s been a noticeable stabilization in health care M&A activity this quarter, despite significant pressures weighing on the sector,” said Avery Swett, editorial analyst at Irving Levin Associates, which publishes the data on its LevinPro HC platform.

The value of third-quarter deals totaled about $44 billion. Although this was 8% less than the second-quarter value, it still was 6% greater than during the same period previous year. The largest deal by price was TowerBrook Capital Partners’ and Clayton, Dubilier & Rice’s $8.9 billion acquisition of R1 RCM, a Chicago-based revenue-cycle management company focused on transforming the patient experience and financial performance of providers.

Activity in sectors such as physician medical groups and other services drove much of the volume in the third quarter, with 112 and 140 deals, respectively. Among other sectors:

Related: Health care M&A: Pharma makes moves, hospitals consolidate, scrutiny grows

“While challenges remain in areas like behavioral health and home health, we’re seeing resilient demand for physician medical groups and health care real estate, which continue to fuel deal flow,” Swettt said. “Looking ahead, the lower- and middle-market segments, driven by private equity and larger health systems, are likely to remain active as they navigate ongoing industry consolidation.”